Institutional Perspectives in Cancer: Multiple Myeloma
This event is in the past.
Featuring Jeffrey Zonder, M.D., oncologist and hematologist; and oncologists Andrew Kin, M,D,; Craig Cole, M.D.; and Abhinav Deol, M.D.
Topics include: How has BCMA-Targeted Therapy Changed the Treatment Landscape for MM?, Proteasome Inhibitors in MM, Future of Multiple Myeloma: Bispecific Antibodies, CAR T-cell Therapy in MM.
OncLive® Institutional Perspectives in Cancer (IPC) are short virtual meetings designed to educate oncologists and health care providers on the clinical benefits associated with the new science driving updates in cancer management.
Register at https://event.onclive.com/event/467edce1-bb15-45d8-897f-015e9d8c1efc/regProcessStep1?RefId=flyer
Karmanos Cancer Institute